Quantcast

Latest keratoconus Stories

2011-02-01 21:44:45

New surgical approach may help meet demand for donor corneas German researcher Claus Cursiefen, MD, also affiliated with Harvard School of Medicine, reports good results with a new surgical strategy that uses a single donor cornea to help two patients with differing corneal diseases. In the United States keeping pace with demand for donated corneal tissue for use in transplant surgery is a cause for concern, while in Europe and Asia shortages lead to treatment delays. Dr. Cursiefen's new...

2010-12-21 07:20:00

CARLSBAD, Calif., Dec. 21, 2010 /PRNewswire/ -- This holiday season patients are receiving the life-changing gift of clear and comfortable vision thanks to the Sharing Vision Grant Program sponsored by SynergEyes, Inc. This program was created to bring the new technologically advanced ClearKone® hybrid contact lens to keratoconus patients who may otherwise not have access. Keratoconus is a degenerative eye disease that occurs 1 in 1,000 people causing substantially...

2010-09-24 07:15:00

CARLSBAD, Calif., Sept. 24 /PRNewswire/ -- SynergEyes, Inc., the developer of ClearKone(R), the FDA-cleared hybrid contact lens specifically designed to treat keratoconus, has launched a new educational website, http://www.treatkeratoconus.com, for patients seeking information and treatment options for the eye disease keratoconus. Keratoconus is a debilitating eye condition in which the cornea thins and becomes cone-shaped and irregular rather than spherical like a normal cornea and can...

2010-09-22 05:00:00

BEVERLY HILLS, Calif., Sept. 22 /PRNewswire/ -- After ten years of dedication to developing new, innovative treatments to help patients with Keratoconus, a degenerative eye disease that affects millions of people worldwide and can cause severe loss of vision, Dr. Brian S. Boxer Wachler, MD is to receive one of the highest honors a physician can achieve. On Thursday evening, September 23, Dr. Boxer Wachler will receive the Jules Stein Living Tribute Award at the 2010 Vision Awards. (Logo:...

2010-09-21 11:05:53

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia. Keratoconus is a disease of the cornea, the clear front lens of the eye (like the crystal on a watch), that occurs in the overall population at a rate of about one in 2000. It usually begins...

2010-09-16 11:40:00

TEANECK, N.J., Sept. 16 /PRNewswire/ -- The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia. Keratoconus is a disease of the cornea, the clear front lens of the eye (like the crystal on a watch), that occurs in the overall population at a...

f7f3bfba9daf212e58cea0a65a0619ac1
2010-08-26 06:50:00

A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans. The results, from an early phase clinical trial with 10 patients, were published in the August 25th, 2010 issue of Science Translational Medicine. "This study is important because it is the first to show that an artificially fabricated cornea can integrate with the human eye and stimulate regeneration," said senior author Dr. May...

2010-07-01 16:47:09

Although it is already one of medicine's most successful transplant procedures, doctors continue to seek ways to improve corneal transplants. Now, for the first time, a team of German and British researchers have confirmed that failure and rejection of transplanted corneas are more likely in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, prior to surgery. The meta-analysis report appears in July Ophthalmology, the journal of the American Academy of...

2010-06-21 17:40:00

LOS ANGELES, June 21 /PRNewswire/ -- No one may remember, but Derek Fisher was in constant combat against two unique adversaries on the court: his contact lens as well as the opposing team, much like Superman battling two enemies at once. Over ten years ago, Los Angeles eye surgeon Dr. Brian Boxer Wachler, MD witnessed an episode of "Derek vs. the Contact Lens and the Visiting Team." During a game, a lens suddenly popped out. Everything was brought to a screeching halt as Derek dropped...

2010-06-01 08:30:00

BEVERLY HILLS, Calif., June 1 /PRNewswire/ -- Lafe Thompson, an Ohio based iron worker, had all but given up hope that the life that he knew would ever be the same. Diagnosed with Keratoconus, a devastating degenerative eye disease that weakens the cornea, Thompson underwent traditional surgeries to correct the problem, only to find his vision continuing to fail. Unable to drive or perform ordinary tasks, Lafe eventually lost his job in ironwork along with his ability to support his family....


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related